Advanced Search
Contact | Corporate | Help

Safety and Efficacy Study of SAR 1118 to Treat Dry Eye

Sponsors:
  • SARcode Bioscience
Phases:
  • Phase III
IndicationsAcronym:
OPUS-1
  • Dry Eye
  • Keratoconjunctivitis Sicca
Age Groups:
  • Adult
  • Senior
Gender:
Both
Names:
  • Drug: SAR 1118
Enrollment:
588

Additional information about NCT01421498.


SourceSolution © 2008-2012